Valganciclovir 71921-0210-12

Package NDC

71921-0210-12

Product NDC: 71921-0210

Manufacturer: Florida Pharmaceutical Products, Llc
Dosage Form: Powder, For Solution
Route: Oral
Product Type: Human Prescription Drug
Marketing Start: July 1, 2023
Listing Expires: December 31, 2026
Application: ANDA216317

Need to source Valganciclovir? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.

Find Supply →Sponsored

Active Ingredients

Ingredient	Strength
Valganciclovir	50 mg/mL

Drug Class

Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]DNA Polymerase Inhibitors [MoA]

Selected Package

71921-0210-12Selected

1 BOTTLE in 1 CARTON (71921-210-12) / 100 mL in 1 BOTTLE